This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop on frontotemporal dementia (FTD) and ALS held in London, Canada in June 2015. Since the publication of the Strong criteria, there have been considerable advances in the understanding of the neuropsychological profile of patients with ALS. Not only is the breadth and depth of neuropsychological findings broader than previously recognised – – including deficits in social cognition and language – but mixed deficits may also occur. Evidence now shows that the neuropsychological deficits in ALS are extremely heterogeneous, affecting over 50% of persons with ALS. When present, these deficits significantly and adversely impact patient survival. It is the recognition of this clinical heterogeneity in association with neuroimaging, genetic and neuropathological advances that has led to the current re-conceptualisation that neuropsychological deficits in ALS fall along a spectrum. These revised consensus criteria expand upon those of 2009 and embrace the concept of the frontotemporal spectrum disorder of ALS (ALS-FTSD).

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD) : revised diagnostic criteria / M.J. Strong, S. Abrahams, L.H. Goldstein, S. Woolley, P. Mclaughlin, J. Snowden, E. Mioshi, A. Roberts-South, M. Benatar, T. Hortobágyi, J. Rosenfeld, V. Silani, P.G. Ince, M.R. Turner. - In: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. - ISSN 2167-8421. - 18:3-4(2017 Apr 03), pp. 153-174. [10.1080/21678421.2016.1267768]

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD) : revised diagnostic criteria

V. Silani;
2017

Abstract

This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop on frontotemporal dementia (FTD) and ALS held in London, Canada in June 2015. Since the publication of the Strong criteria, there have been considerable advances in the understanding of the neuropsychological profile of patients with ALS. Not only is the breadth and depth of neuropsychological findings broader than previously recognised – – including deficits in social cognition and language – but mixed deficits may also occur. Evidence now shows that the neuropsychological deficits in ALS are extremely heterogeneous, affecting over 50% of persons with ALS. When present, these deficits significantly and adversely impact patient survival. It is the recognition of this clinical heterogeneity in association with neuroimaging, genetic and neuropathological advances that has led to the current re-conceptualisation that neuropsychological deficits in ALS fall along a spectrum. These revised consensus criteria expand upon those of 2009 and embrace the concept of the frontotemporal spectrum disorder of ALS (ALS-FTSD).
Amyotrophic lateral sclerosis; behaviour; cognition; frontotemporal dementia; genetics; neuropsychology; Neurology; Neurology (clinical)
Settore MED/26 - Neurologia
3-apr-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
Strong M.J. ALS_FTD 2017.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 648.57 kB
Formato Adobe PDF
648.57 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
21678421.2016.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 910.6 kB
Formato Adobe PDF
910.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/481275
Citazioni
  • ???jsp.display-item.citation.pmc??? 177
  • Scopus 557
  • ???jsp.display-item.citation.isi??? 512
social impact